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Abstract: Rickettsia felis was described as a human pathogen almost two decades ago, and 
human infection is currently reported in 18 countries in all continents. The distribution of this 
species is worldwide, determined by the presence of the main arthropod vector, Ctenocephalides 
felis (Bouché). The list of symptoms, which includes fever, headache, myalgia, and rash, keeps 
increasing as new cases with unexpected symptoms are described. Moreover, the clinical presen-
tation of R. felis infection can be easily confused with many tropical and nontropical diseases, 
as well as other rickettsial infections. Although specific laboratory diagnosis and treatment 
for this flea-borne rickettsiosis are detailed in the scientific literature, it is possible that most 
human cases are not being diagnosed properly. Furthermore, since the cat flea infests different 
common domestic animals, contact with humans may be more frequent than reported. In this 
review, we provide an update on methods for specific detection of human infection by R. felis 
described in the literature, as well as the treatment prescribed to the patients. Considering 
advances in molecular detection tools, as well as options for as-yet-unreported isolation of 
R. felis from patients in cell culture, increased diagnosis and characterization of this emerging 
pathogen is warranted.
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Introduction
Rickettsia felis is considered an emerging human pathogen and the etiologic agent of 
flea-borne rickettsiosis, also known as flea-borne spotted fever and cat flea typhus. 
Rickettsioses are arthropod-borne diseases caused by obligate rod-shaped, intracellular 
Gram-negative α-proteobacteria of the genus Rickettsia, which can infect humans and 
different animals.1 The genus Rickettsia has been divided into three major groups based 
on their antigenic and genetic characteristics: (1) the spotted fever group (SFG), which 
includes several nonpathogenic as well as pathogenic species such as the etiological 
agents of Rocky Mountain spotted fever/Brazilian spotted fever (Rickettsia rickettsii), 
Mediterranean spotted fever (R. conorii), flea-borne spotted fever (R. felis), rickettsial 
pox (R. akari), R. massiliae, and R. slovaca; (2) the typhus group (TG), which includes 
the etiological agents of epidemic and endemic typhus (R. prowazekii and R. typhi); 
and (3) the ancestral group, containing R. belli and R. canadensis.2–4 Although a 
fourth group has been proposed more recently, which separates R. akari, R. australis, 
and R. felis from the SFG and places them in a separate group called the transitional 
group,5,6 the validity of a separate group for these species has been debated.7,8
R. felis was first observed by electron microscopy from midgut epithelial cells and 
other tissues of adult cat fleas (Ctenocephalides felis felis), and it was named “ELB” 
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after El-Labs (Soquel, CA).9 A close affinity of ELB to 
R. typhi was demonstrated initially by immunofluorescence 
assays.9,10 Additional characterization of the ELB agent fol-
lowed, and evidence from polymerase chain reaction (PCR) 
amplification, restriction fragment length polymorphism 
(RFLP) analyses, and sequencing of the 17 kDa protein and 
citrate synthase gene (gltA) fragments indicated that ELB was 
distinct from R. typhi.10–12 Other studies confirmed this same 
fact, and description of the organism as R. felis was performed 
by Higgins et al in 1996.13 Initial isolation and cultivation 
had been reported by Radulovic et al,11 but maintenance in 
culture was not possible at the time, and contamination with 
R. typhi was suspected.14 In 2001, Bouyer et al amplified the 
recombinant outer membrane protein A gene (ompA) by PCR, 
a gene present only in SFG rickettsiae.14 Although previous 
evidence from analysis of other gene sequences suggested 
placement of R. felis in the SFG,2,10 this evidence of ompA 
finally confirmed that the new Rickettsia was in fact a member 
of the SFG. Rickettsia felis was further characterized and 
redescribed, and descriptions were emended in 2002.14,15
A study by Merhej et al showed that most genes of R. felis 
genome place it in the SFG clade.8 However, phylogenetic 
analyses of R. felis genes revealed that some of them come 
from a variety of origins, as has been shown for other bac-
teria like Escherichia coli, which demonstrates that not all 
genes show vertical inheritance during evolutionary history 
and that horizontal gene transfer probably occurs. Rickettsia 
felis can acquire new genes horizontally, since it has been 
shown that this species is present in many different hosts,16–28 
and concomitant infections by more than one intracellular 
bacterium may lead to recombination events.8 It has also been 
demonstrated that R. felis can have one, two, or no plasmids, 
which were probably acquired through horizontal exchange 
by conjugation.5,29–31 Although studies have recognized all 
genes in the different R. felis studied, their function is not all 
clear. It would be important in future to determine if those 
newly acquired genes could change characteristics like tro-
pism or antigenicity.
R. felis infection in invertebrate  
and vertebrate animals
The ecology of R. felis has been reviewed previously,22,32–34 
and although it is not the focus of this review, some general 
considerations are presented concerning infection and detec-
tion in vertebrate and invertebrate hosts.
The cat flea, C. felis felis, is considered the primary vector 
and reservoir of R. felis. Detection of R. felis DNA in these 
fleas has been successful everywhere it has been investigated. 
Given that the cat flea is cosmopolitan in distribution, the 
presence of R. felis follows this same pattern, and has been 
already reported in every continent except Antarctica.10,17,35–41 
However, R. felis is not restricted to C. felis, and molecular 
evidence of infection, although less frequent, has been 
reported in other species of arthropods, such as fleas, ticks, and 
mites, including the familiar species Ctenocephalides canis, 
Xenopsylla cheopis, Pulex irritans, Tunga penetrans, 
Echidnophaga gallinacea, Rhipicephalus sanguineus, 
Amblyomma cajennense, chiggers (Trombiculidae), and even 
in nonbiting insects.19,20,22–28,34,35
In most of these cases, the presence of R. felis in arthro-
pods has been confirmed by detection and sequencing or 
RFLP analyses of rickettsia-specific gene fragments, the 
most common being gltA, htrA (17 kDa protein), ompA, and 
ompB.22 Quantitative real-time PCR (qPCR) assays to detect 
R. felis DNA in fleas have also been developed and are useful 
in determining infection load and kinetics.42,43 Conversely, 
successful isolation and culture of R. felis directly from cat 
fleas has been reported only from laboratories in France, 
the US, Brazil, and Costa Rica using cell lines of verte-
brate (XTC-2 and Vero) and arthropod (ISE6 and C6/36) 
origin.36,44–46 No isolation of R. felis from vertebrates has been 
reported. The conditions of cultivation and growth of R. felis 
in different cell lines are described later in this review.
Rickettsia felis is maintained in flea populations mainly 
by transovarial transmission.10,47 Evidence also suggests 
horizontal transmission from other infected fleas or infection 
through a rickettsemic blood meal is likely.48,49 Although 
there is no evidence of fitness loss or increased mortality in 
infected C. felis, results of some studies suggest that R. felis 
may actually increase fitness to facilitate transmission to the 
next generation of fleas or a vertebrate host.43
Infection of vertebrates probably occurs during blood 
feeding of infected fleas, although transmission through 
infective flea feces is possible.47,50 Various domestic and 
peridomestic animals may exhibit evidence of R. felis natu-
ral infection. Antibodies against R. felis can be present in 
animals, including dogs, cats, and opossums, and the pres-
ence of specific DNA fragments has also been detected in 
animals.51–62 Since acquisition of R. felis from blood meal and 
transmission from fleas to animals has been demonstrated in 
laboratory experiments,47,49 cats, dogs, and opossums have 
been considered possible reservoirs.13,53,57,62
Symptomatic disease caused by R. felis infection in 
domestic or wild animals may vary, but a direct causal asso-
ciation has not been proven. One study showed no statisti-
cal association between presence of R. felis antibodies and 
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illness in cats,56 and another report mentions a PCR-positive 
dog with fatigue and digestive symptoms.54 In addition, an 
experimental infection of opossums with R. felis resulted in 
antibody response, although bacteremia was undetectable.61 
Given that isolation of R. felis directly from sick animals 
has not been performed so far and that prevalence of infec-
tion and/or rickettsemia may not be high,56,63–65 there is no 
conclusive evidence at this time to confirm the role of these 
animals as reservoirs or victims of disease.
Human cases of flea-borne  
spotted fever
Human infection with R. felis has already been reported in the 
US,66 Mexico,67–69 Brazil,36 France,36,70 Germany,52 Spain,54,71 
Sweden,72 Israel,73 South Korea,74 Taiwan,75 Thailand,76 
Laos,77 Tunisia,78,79 Egypt,80 Australia,81 Senegal,82 Kenya,83,84 
and New Zealand.85
Clinical findings for R. felis infection may be confused 
with infection due to other rickettsial agents like R. typhi 
and some members of the SFG, as well as other infectious 
diseases like dengue, malaria, brucellosis, leptospirosis, or 
even other clinical conditions like Kawasaki disease.69,77,81,83 
One example of misdiagnosis is a case reported as murine 
typhus diagnosed by serology in 2008, which in 2010 was 
confirmed by PCR as an infection by R. felis and not R. typhi, 
using the patient’s same frozen serum.73
Fever (greater than 38°C), headache, myalgia, and 
maculopapular rash are the most common symptoms.66 The 
presence of a cutaneous eschar at the bite site is possible, 
although it may be infrequent.52,70 Respiratory and digestive 
symptoms, including cough, pulmonary edema, pneumonia, 
nausea, vomiting, and diarrhea, have been reported.35,67,70,86 
Neurological signs have also been documented, such as the 
reports of infection in patients presenting subacute meningitis 
and acute polyneuropathy-like symptoms from Sweden and 
Taiwan, respectively.72,75 Although R. felis infection in most 
cases has been observed as a mild to moderate illness, respi-
ratory, neurologic, and visceral affections can occur, leading 
to complications such as those reported in severe cases from 
Mexico.69 Although no deaths attributed to R. felis infection 
are reported in the literature, the first two cases reported from 
Brazil presented stupor, and one of them coma.36
During R. felis infection, laboratory results for tests 
like hematocrit and hemoglobin are usually in the normal 
range, but some patients have severe thrombocytopenia 
and elevated bilirubin (2.7–3.1 mg/dL), which presents as 
jaundice.69 The most common abnormalities are associ-
ated with increased aminotransferase levels: aspartate 
aminotransferase (85–108 U/L) and alanine aminotransferase 
(135–160 U/L).69,70,81
Knowledge of epidemiological context, clinical history, 
signs, symptoms, and general laboratory tests are important 
for diagnosis of rickettsial diseases. Since infection with 
R. felis can cause illness anywhere from mild to moderate to 
severe, it may be confused with signs and symptoms of other 
infectious and noninfectious diseases. Therefore, diagnosis 
of flea-borne spotted fever requires specific laboratory tests 
to detect R. felis infection.
Laboratory detection  
of R. felis infection in humans
Methods for detection of R. felis infection in humans are 
derived from the general methods used in diagnosis for rick-
ettsial diseases. Although the general principles and applica-
tions of these methods have been reviewed previously,3,87,88 
the following section describes their applications in detection 
of specific R. felis infection.
Detection of antibodies
Specific methods for the diagnosis of rickettsial diseases of 
the SFG in humans started in the late 1960s utilizing sero-
logic tests, the immunofluorescent antibody assay being the 
reference method for detection of specific antibodies to SFG 
rickettsiae.89,90 The most important limitation of serologic 
tests is the cross-reaction that occurs between species of rick-
ettsiae within the same group and sometimes even between 
groups. Although this cross-reaction is common between 
species,91–93 immunofluorescence is considered the reference 
method for diagnosis of rickettsial infection.3,87,88 It is also 
the first step towards the diagnosis and screening of rick-
ettsial diseases for mainly nonendemic geographic areas.94 
Twofold serial dilutions of the sera should be performed to 
determine an end titer using antigens from one or more spe-
cies of rickettsiae. Absorption of sera with complementary 
rickettsiae can be useful when cross-reactivity occurs, and 
Western blot may also aid in species identification.3,95
Detection of antibodies to SFG or TG rickettsiae in human 
infections with R. felis has been performed by immunofluo-
rescence methods in some of the cases reported, although 
species confirmation has been determined by other means 
(Table 1). A general guideline used for identification of the 
rickettsial agent responsible is mentioned in several of the 
reports.3 According to this, if cross-reactivity occurs, a higher 
titer of antibodies to R. felis in comparison to other species 
(usually by two or more serial dilutions) would suggest 
specific infection by R. felis or a very similar species.36,76 
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Table 1 Summary of Rickettsia felis–specific diagnostic/confirmatory methods and treatment reported in human infection
Country Year of  
publication
N cases  
confirmed
R. felis-specific detection  
and identification methods*
Specific R. felis treatment  
and outcome
Reference
USA 1994 1 PCR 17-kDa protein gene fragment 
RFLP Southern hybridization
Doxycycline 66
Brazil 2001 2 MIF antibody titers to R. felis higher  
by two or more dilutions 
Nested PCR gltA gene fragment,  
sequencing (1 patient)
NI 36
Mexico 2000 
 
2006 
 
2009
3 
 
1 
 
2
PCR 17-kDa protein gene  
fragment; sequencing 
PCR 17-kDa protein gene  
fragment, sequencing 
PCR gltA, ompA, ompB, gene  
fragments, sequencing and RFLP
Doxycycline 2 weeks (one patient),  
recovered 
Doxycycline, discharged after 1 week 
Chloramphenicol  
(IV 75 mg/kg per day for 10 days),  
both recovered within 5 days
67 
 
68 
 
69
France 2001 
 
2009
2 
 
1
MIF antibody titers to R. felis  
higher by two or more dilutions 
MIF, R. felis confirmed by Western  
blot with cross-adsorption
NI 
 
Doxycycline, rapid improvement
36 
 
70
Germany 2002 1 Seroconversion, MIF antibody titers to  
R. felis higher by two or more dilutions,  
species confirmed by Western blot 
Nested PCR for PS120 protein  
gene fragment
Doxycycline (200 mg/day for 7 days),  
recovered within 3 days
52
Thailand 2003 1 MIF antibody titers to R. felis higher by  
two or more dilutions, species  
confirmed by Western blot
Doxycycline (200 mg/day for 7 days) 76
South  
Korea
2005 3 Nested PCRs ompB and gltA gene  
fragments, RFLP and sequencing
NI 74
Spain 2005 
 
 
2006
5 
 
 
2
MIF antibody titers to R. felis higher by  
two or more dilutions, species confirmed  
by western blot with cross-adsorption 
Nested PCRs gltA and ompB gene fragment,  
seminested PCR ompA, sequencing
NI 
 
 
Doxycycline (200 mg/day for 10 days),  
recovered within 2 days
54 
 
 
71
Tunisia 2006 
2009
8 
1
MIF, western blot with cross-adsorption 
MIF, western blot with cross-adsorption
NI 
Tetracycline and doxycycline
78 
79
Laos 2006 1 MIF, western blot with cross-adsorption NI 77
Egypt 2007 1 Quantitative real-time PCR specific  
for R. felis ompB gene fragment
NI 80
Israel 2010 1 Quantitative real-time PCR specific  
for R. felis ompB gene fragment
Doxycycline 73
Kenya 2010 
 
 
 
 
2012
6 
 
 
 
 
21
Quantitative real-time and nested PCR  
17 kDa protein gene fragments, sequencing 
Quantitative real-time PCR specific for  
R. felis ompB gene fragment 
Nested PCR ompB gene fragment, sequencing 
PCR R. felis plasmid 
PCR 17-kDa protein gene, ompB,  
R. felis plasmid gene fragments, sequencing 
Quantitative real-time PCR specific  
for R. felis ompB gene fragment
NI 
 
 
 
 
NI
83 
 
 
 
 
84
Australia 2011 5 (probable) MIF, high titers or seroconversion  
to TG rickettsiae 
PCR gltA gene fragment from  
cat fleas, sequencing
Doxycycline (one patient),  
improved
81
Senegal 2010 8 Quantitative real-time and nested  
PCR gltA gene fragments, sequencing 
Quantitative real-time PCR biotin synthase  
R. felis-specific gene fragment
NI 82
(Continued)
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Table 1 (Continued)
Country Year of  
publication
N cases  
confirmed
R. felis-specific detection  
and identification methods*
Specific R. felis treatment  
and outcome
Reference
Taiwan 2008 1 Quantitative real-time PCR 17-kDa protein,  
groEL, ompB gene fragments, sequencing
Doxycycline (oral 100 mg  
every 12 hours for 5 days)
75
Sweden 2010 2 Quantitative real-time PCR gltA; nested  
PCR 17-kDa protein and ompB gene  
fragments, sequencing
Nonspecific antibiotics 72
New  
Zealand
2012 2 MIF, R. felis confirmed by Western  
blot with cross-adsorption
NI 85
Note: *PCRs not specific for R. felis unless otherwise stated.
Abbreviations: PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; MIF, microimmunofluorescence; NI, not indicated or not applicable.
In addition, confirmation of R. felis antibodies has been 
performed by Western blot and/or cross-adsorption 
analyses.70,71,76–78 However, these methods may not determine 
the species of Rickettsia responsible in every case.52,71,78,85
The presence of immunoglobulin G (IgG) antibodies in 
humans, which probably represent past infection with R. felis, 
has been demonstrated and may be relatively frequent.85,93,96 
Considering that the presence of IgG antibodies to R. felis 
does not necessarily mean current infection, demonstration 
of specific seroconversion to R. felis is required and has been 
used to confirm the presence of R. felis using immunological 
methods.52 However, this is not without limitations, since 
seroconversion for IgG may appear a month or more after 
rickettsial infection.
Molecular methods
Rickettsia felis infection has been frequently diagnosed by 
PCR amplification of targeted genes. Samples are usually 
whole blood or serum, although highly sensitive nested 
and/or real-time PCR assays may be required to detect very 
low concentrations of rickettsial DNA present in serum. In 
a recent report from Sweden, R. felis DNA was detected 
in cerebrospinal fluid from two patients.72 The genes 
most commonly amplified are gltA, ompB, and htrA. The 
ompA gene has also been used, although detection can be 
variable.54,69 Several of the published reports indicate that 
R. felis was detected by amplifying more than two genes, 
and amplicons were confirmed as R. felis by sequencing in 
most cases (Table 1).
Sequencing of PCR products is usually necessary in 
order to get a definitive identification, considering that 
these genes are present in all SFG rickettsiae and only 
specific variations in each sequence allow differentia-
tion. It has been difficult to properly standardize qPCR to 
separate between different SFG rickettsiae; nevertheless, 
real-time PCR methods have been developed specifically 
for R. felis gene fragments, including ompB and the biotin 
synthase gene.42,82,97 This approach has been used to detect 
R. felis-specific infection in humans, which eliminates the 
need for sequencing (Table 1).73,80,82,83
Isolation in cell culture
Isolation of R. felis from human cases in cell culture has 
not been reported; it has only been documented from 
invertebrates. The best samples for isolation attempts, as is 
true for other SFG rickettsiae, would be blood and skin biop-
sies, mainly from the eschar zone if present.3,87 Although 
different cells like Vero (primate), XTC-2 (amphibian), 
C6/36 (Aedes albopictus), ISE6 (tick), Aa23 (A. albopic-
tus), Sua5B (Anopheles gambiae), L929 (mouse), and 
HUVEC (human) have been shown to support R. felis 
growth,11,36,44–46,98–101 the cell lines have either not been suc-
cessful for isolation of R. felis from human samples, or this 
has not been attempted. 
Successful isolates from fleas reported, for instance, that 
R. felis was detected in XTC-2 cells after 14 days in initial 
isolation and after 6 days in subsequent passages, while 
growth was half the rate in Vero cells.36 Initial detection 
of R. felis growth in cell culture is usually determined by 
Giménez stain. Growth is optimal at 28°C in XTC-2 cells, 
and growth has been demonstrated at 28°C and 32°C in 
Vero, room temperature in Aa23 and Sua5B, 25°C and 
28°C in C6/36, and 32°C in ISE6 cell lines.36,44–46,98 Plaque 
production is reported at 9 and 18 days in XTC-2 and Vero 
cells, respectively,15 while almost 100% infection is reported 
in Aa23 and Sua5B cells within 7 days of passaging.98
Isolation and propagation reports show that R. felis grows 
better at lower temperatures, in agreement with the usual con-
ditions of their invertebrate host. Since optimal temperature 
for growth of mammalian cells is usually higher, replication 
of R. felis may be reduced or does not occur. Nevertheless, 
Saisongkorh et al report the establishment of R. felis for up 
to ten passages in mammalian cells (Vero and L 929) at 
28°C, enhanced by using 4% of tryptose phosphate broth 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
51
Detection and treatment of Rickettsia felis
Research and Reports in Tropical Medicine 2012:3
as a supplement in minimum essential medium (MEM) cell 
culture medium with 2% fetal bovine serum.101
Growth of R. felis in these various vertebrate and inver-
tebrate cell lines is possible, although isolation from human 
or other vertebrates has not been reported in the literature. 
In other species such as R. rickettsii, different strains have 
shown varying virulence depending on the vector or host 
species of isolation.102,103 Therefore it is of utmost importance 
to attempt isolation of the bacterium, especially from human 
cases with apparent disease. If culture is successful, isolates 
of R. felis from symptomatic patients would allow further 
characterization of virulence factors, pathogenic potential, 
and course of infection of these pathogenic strains.
Clinical treatment
Whenever signs and symptoms suggest rickettsial disease, 
treatment should be started immediately, even before laboratory 
diagnosis is complete. Doxycycline (200 mg per day) is the 
antibiotic of choice for spotted fever rickettsioses.104–106 
These general guidelines have also been applied in flea-borne 
rickettsiosis (Table 1). For pregnant patients or patients 
who are allergic to this drug, disease may be treated with 
chloramphenicol. In severe cases, intravenous antibiotic is 
recommended for at least 24–48 hours after defervescence 
of fever. As with other rickettsioses, doxycycline is the anti-
biotic of choice for complicated cases of flea-borne typhus, 
although chloramphenicol has been used successfully to treat 
severe cases.69 Recently, josamycin, a macrolide antibiotic, 
and fluoroquinolones have been used in other rickettsioses,3,107 
and they could also be effective against R. felis.
Although infection with R. felis may be self-limiting, 
disease should be treated due to the possibility of severe ill-
ness and complications.62,72,75 The prompt and specific labo-
ratory diagnosis of the diseases is very important, not only 
because it will help the patient’s condition, but also in order 
to avoid using other antibiotics that may lead to selection of 
resistant bacteria, or other useless therapies like intravenous 
immunoglobulin in cases where Kawasaki disease has been 
suspected.81
Conclusion
The present review endorses the importance of R. felis as 
a pathogen to be considered in human cases presenting 
clinical symptoms that are common to many infectious 
diseases caused by different rickettsial species and other 
microorganisms. Human cases of flea-borne spotted fever 
have been described to date in almost 20 countries around 
the world. Since the main vector and reservoir, C. felis felis, 
is a common ectoparasite of dogs and cats globally, infection 
by R. felis is probably more common than reported. Misdi-
agnosis may be frequent in many cases due to poor aware-
ness and information, as well as minimum or no availability 
of specific laboratory testing required to implicate R. felis 
directly. Although symptomatic cases are usually mild, there 
are reports of severe disease where treatment is essential. 
Considering that R. felis infections can be treated in the 
same manner as other rickettsiae (doxycycline is the drug 
of choice), timely diagnosis and treatment is important to 
prevent complications and severe outcomes. Therefore, public 
health authorities should increase awareness and diagnosis 
of R. felis, especially in developing countries, in order to 
recognize the presence of this global emerging disease.
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